Cargando…

Short report: Vaccine attitudes in the age of COVID-19 for a population of children with mitochondrial disease()()

BACKGROUND: Children with developmental disabilities are vulnerable to morbidity associated with COVID-19. AIMS: To understand attitudes toward routine childhood vaccinations versus the COVID-19 vaccine in a population of families affected by mitochondrial disease (MtD), a form of developmental disa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon-Lipkin, Eliza, Marcum, Christopher Steven, Kruk, Shannon, Thompson, Elizabeth, Yeske, Philip, Martin, Lori, McGuire, Peter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pergamon Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510065/
https://www.ncbi.nlm.nih.gov/pubmed/36201931
http://dx.doi.org/10.1016/j.ridd.2022.104346
_version_ 1784797369978585088
author Gordon-Lipkin, Eliza
Marcum, Christopher Steven
Kruk, Shannon
Thompson, Elizabeth
Yeske, Philip
Martin, Lori
McGuire, Peter J
author_facet Gordon-Lipkin, Eliza
Marcum, Christopher Steven
Kruk, Shannon
Thompson, Elizabeth
Yeske, Philip
Martin, Lori
McGuire, Peter J
author_sort Gordon-Lipkin, Eliza
collection PubMed
description BACKGROUND: Children with developmental disabilities are vulnerable to morbidity associated with COVID-19. AIMS: To understand attitudes toward routine childhood vaccinations versus the COVID-19 vaccine in a population of families affected by mitochondrial disease (MtD), a form of developmental disability. METHODS AND PROCEDURES: An online survey was administered via several advocacy groups for children with MtD. OUTCOMES AND RESULT: Eighty-six percent of families reported being up to date with the childhood vaccine schedule and seventy percent reported that their affected child receives the annual flu shot. However, only fifty percent reported that the benefits of the COVID-19 vaccine outweighed the risk for their affected child. One quarter of families expressed concern that their child may become sick or deteriorate after the COVID-19 vaccine. In comparison to other routine childhood vaccines, families expressed less confidence in the COVID-19 vaccine. CONCLUSIONS AND IMPLICATIONS: Families affected by this population of developmental disabilities are more comfortable with the vaccines included in the routine childhood immunization schedule than with the newly introduced COVID-19 vaccine, even despite this group’s vulnerability.
format Online
Article
Text
id pubmed-9510065
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Pergamon Press
record_format MEDLINE/PubMed
spelling pubmed-95100652022-09-26 Short report: Vaccine attitudes in the age of COVID-19 for a population of children with mitochondrial disease()() Gordon-Lipkin, Eliza Marcum, Christopher Steven Kruk, Shannon Thompson, Elizabeth Yeske, Philip Martin, Lori McGuire, Peter J Res Dev Disabil Article BACKGROUND: Children with developmental disabilities are vulnerable to morbidity associated with COVID-19. AIMS: To understand attitudes toward routine childhood vaccinations versus the COVID-19 vaccine in a population of families affected by mitochondrial disease (MtD), a form of developmental disability. METHODS AND PROCEDURES: An online survey was administered via several advocacy groups for children with MtD. OUTCOMES AND RESULT: Eighty-six percent of families reported being up to date with the childhood vaccine schedule and seventy percent reported that their affected child receives the annual flu shot. However, only fifty percent reported that the benefits of the COVID-19 vaccine outweighed the risk for their affected child. One quarter of families expressed concern that their child may become sick or deteriorate after the COVID-19 vaccine. In comparison to other routine childhood vaccines, families expressed less confidence in the COVID-19 vaccine. CONCLUSIONS AND IMPLICATIONS: Families affected by this population of developmental disabilities are more comfortable with the vaccines included in the routine childhood immunization schedule than with the newly introduced COVID-19 vaccine, even despite this group’s vulnerability. Pergamon Press 2022-12 2022-09-26 /pmc/articles/PMC9510065/ /pubmed/36201931 http://dx.doi.org/10.1016/j.ridd.2022.104346 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Gordon-Lipkin, Eliza
Marcum, Christopher Steven
Kruk, Shannon
Thompson, Elizabeth
Yeske, Philip
Martin, Lori
McGuire, Peter J
Short report: Vaccine attitudes in the age of COVID-19 for a population of children with mitochondrial disease()()
title Short report: Vaccine attitudes in the age of COVID-19 for a population of children with mitochondrial disease()()
title_full Short report: Vaccine attitudes in the age of COVID-19 for a population of children with mitochondrial disease()()
title_fullStr Short report: Vaccine attitudes in the age of COVID-19 for a population of children with mitochondrial disease()()
title_full_unstemmed Short report: Vaccine attitudes in the age of COVID-19 for a population of children with mitochondrial disease()()
title_short Short report: Vaccine attitudes in the age of COVID-19 for a population of children with mitochondrial disease()()
title_sort short report: vaccine attitudes in the age of covid-19 for a population of children with mitochondrial disease()()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510065/
https://www.ncbi.nlm.nih.gov/pubmed/36201931
http://dx.doi.org/10.1016/j.ridd.2022.104346
work_keys_str_mv AT gordonlipkineliza shortreportvaccineattitudesintheageofcovid19forapopulationofchildrenwithmitochondrialdisease
AT marcumchristophersteven shortreportvaccineattitudesintheageofcovid19forapopulationofchildrenwithmitochondrialdisease
AT krukshannon shortreportvaccineattitudesintheageofcovid19forapopulationofchildrenwithmitochondrialdisease
AT thompsonelizabeth shortreportvaccineattitudesintheageofcovid19forapopulationofchildrenwithmitochondrialdisease
AT yeskephilip shortreportvaccineattitudesintheageofcovid19forapopulationofchildrenwithmitochondrialdisease
AT martinlori shortreportvaccineattitudesintheageofcovid19forapopulationofchildrenwithmitochondrialdisease
AT mcguirepeterj shortreportvaccineattitudesintheageofcovid19forapopulationofchildrenwithmitochondrialdisease